Physician profile
Stanton M Malowitz
NPI 1861789679
$1,791.52
in general payments reported to CMS, 2019-2025
19 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $155 · 2021: $349 · 2022: $96.80 · 2023: $169 · 2024: $503 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.29 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $539.67 | 2019-2022 | |
| Genzyme Corporation | $300.38 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $234.81 | 2021-2024 | Gattex, Eohilia, Vpriv |
| Qol Medical, LLC | $129.94 | 2019-2023 | Sucraid |
| Harmony Biosciences LLC | $114.40 | 2024-2025 | |
| Baxter Healthcare | $68.84 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Pharming Healthcare, INC. | $60.86 | 2024-2025 | Ruconest |
| Philips North America LLC | $56.64 | 2019-2021 | |
| Advanced Respiratory, INC | $48.28 | 2019 | |
| Electromed, INC. | $47.78 | 2019 | |
| Ironwood Pharmaceuticals, INC | $47.54 | 2023 | Linzess |
| Mauna Kea Technologies, INC. | $23.45 | 2025 | |
| Alcresta Therapeutics, INC. | $22.97 | 2024 | Relizorb |
| Regeneron Healthcare Solutions, INC. | $22.74 | 2023 | Dupixent |
| Mirum Pharmaceuticals, INC. | $17.91 | 2023 | Livmarli |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $16.86 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $15.31 | 2024 | Kristalose |
| Phadia US INC. | $12.15 | 2020 | |
| Intercept Pharmaceuticals, INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanton Malowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.